Bio-Rad Laboratories Inc. Class A (BIO)

Bio-Rad Laboratories Inc. Class A (BIO $301.50)
- $301.50 Cap: $8.25B
- View BIO Profile
- View Questions on BIO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 167.19X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $110.83)
- $110.83 P/E (TTM): 13.69X Cap: $192.71B
- View ABT Profile
- View Questions on ABT
Danaher Corporation (DHR $216.61)
- $216.61 P/E (TTM): 44.39X Cap: $153B
- View DHR Profile
- View Questions on DHR
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 49.94X Cap: $1T
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $358.29)
- $358.29 P/E (TTM): 47.62X Cap: $137.01B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $542.83)
- $542.83 P/E (TTM): 31.33X Cap: $203.94B
- View TMO Profile
- View Questions on TMO
UnitedHealth Group Incorporated (DE) (UNH $276.65)
- $276.65 P/E (TTM): 14.01X Cap: $250.60B
- View UNH Profile
- View Questions on UNH
Zoetis Inc. Class A (ZTS $127.42)
- $127.42 P/E (TTM): 21.34X Cap: $56.15B
- View ZTS Profile
- View Questions on ZTS
DexCom Inc. (DXCM $69.97)
- $69.97 P/E (TTM): 39.04X Cap: $27.28B
- View DXCM Profile
- View Questions on DXCM
STERIS plc (Ireland) (STE $252.16)
- $252.16 P/E (TTM): 35.03X Cap: $24.74B
- View STE Profile
- View Questions on STE
Bio-Rad Laboratories Inc. Class A (BIO $301.50)
- $301.50 Cap: $8.25B
- View BIO Profile
- View Questions on BIO

Q: Hello,

I'm looking to buy 4 or 5 US medical stocks for a long-term hold (5+ years) with an above-average level of risk tolerance.

Could you please rank the stocks I've listed, and indicate if there are better choices.

Thank you!

Read Answer Asked by Barbara on March 15, 2022